Christopher Kent, Reveal Surgical - AI-Enabled Optical Detection | LSI Europe '22

Reveal Surgical's Sentry system is using advanced optical techniques such as Raman spectroscopy along with sophisticated machine learning algorithms to identify tissues with diffusely infiltrative cancer in vivo, while in surgery.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Christopher Kent
Christopher Kent
President & CEO, Reveal Surgical